Partnering
Accelerating Innovation Through Long-Term and Win-Win Partnerships
Global Network, Open and Win-Win
We believe strong partnerships drive progress towards new medicines for patients.
At Ribo, we combine world-class oligonucleotide discovery capabilities with proven technology to advance siRNA projects within our pipeline globally.
We actively seek strategic collaborations within the siRNA field, and partnerships to accelerate the advancement of our high-potential assets and co-create value with partners.
Ideal Partners We Are Looking For
Collaborate on diseases we can target via the liver, metabolic disorders, cardiovascular diseases, and obesity
Work together with others on kidney diseases, and targeting the CNS and potentially other tissues and cells
Share our proven expertise in innovative drug development, with strong clinical and regulatory capabilities
Work with partners with strong commercial capabilities and global market insight
-
Platform Collaboration
-
Asset Licensing
-
Combination Therapeutic
-
Co-Development
We welcome the opportunity to connect with you and to explore potential collaborations.
